A Form 4 filed on August 19, 2026 reports that Rosemary Turner, a director of Murphy USA Inc. (NYSE:MUSA), received shares of common stock on August 17, 2026 following the vesting and settlement of Restricted Stock Units awarded under two separate equity plans.
Key Highlights
- Reporting person: Rosemary Turner, identified as a Director of Murphy USA Inc.
- Transaction date: Both transactions occurred on August 17, 2026.
- Shares acquired (first tranche): 617 shares of common stock acquired at $0, via vesting of RSUs under the 2013 Stock Plan for Non-employee Directors.
- Shares acquired (second tranche): 449 shares of common stock acquired at $0, via vesting of RSUs under the 2023 Omnibus Incentive Plan.
- Total direct beneficial ownership following transactions: 1,415 shares of common stock held directly.
- Remaining derivative securities: 871.522 RSU units remaining under the first award and 422.154 under the second, both held directly.
RSU Vesting Details for Murphy USA Director Rosemary Turner
According to the filing, Rosemary Turner, a director of Murphy USA Inc., reported two RSU vesting events on August 17, 2026. The first involved 617 shares of common stock acquired through the settlement of 617.442 Restricted Stock Units granted under the company's 2013 Stock Plan for Non-employee Directors. The second involved 449 shares acquired through the settlement of 449.368 RSUs granted under the 2023 Omnibus Incentive Plan. Both transactions carry a transaction code of "M" and a price of $0, consistent with RSU vesting.
The filing states that the shares "represent Restricted Stock Units and corresponding dividend equivalents accrued thereon granted to the Reporting Person that have vested and settled in shares of the Company's stock on a one-for-one basis, except for fractional dividend equivalents which have been settled in cash." Following the two transactions, Turner's direct beneficial ownership of common stock stood at 1,415 shares, according to the filing.
On the derivative side, the filing reports that Turner held 871.522 RSU units remaining under the first award and 422.154 RSU units under the second, both directly owned. The filing notes that these RSUs "generally do not carry a Conversion Price, Exercisable Date, or Expiration Date." The form was signed by Gregory L. Smith as attorney-in-fact on August 19, 2026.
What Was Disclosed
The filing discloses two RSU vesting transactions by Murphy USA director Rosemary Turner on August 17, 2026, resulting in the acquisition of a combined 1,066 shares of common stock at $0 and a post-transaction direct holding of 1,415 shares.



Please wait processing your request...